Cidara Therapeutics, Inc. — Director's Dealing 2019

Sep 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2019-09-24

Reporting Person: Stein Jeffrey (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-24	Common Stock	P	52500	$1.9067	Acquired	225619	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	282320	Direct
Common Stock	15709	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.84
to $1.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set
forth above.